Sermorelin, Ipamorelin, and CJC-1295 Dosage: What Common Protocols Look Like

There is no single FDA-approved sermorelin ipamorelin cjc1295 dosage, because these three peptides act on different targets and only one of them has ever held FDA approval. Typical research and clinical protocols use sermorelin at roughly 100–300 mcg at bedtime, ipamorelin at 100–300 mcg one to three times daily, and CJC-1295 at 100 mcg per dose without DAC or 1–2 mg once or twice weekly with DAC.

Doses are measured in micrograms, and timing around food and sleep often matters as much as the number itself. Everything below reflects published research and commonly used protocols, not a guaranteed prescription plan.

Sermorelin, Ipamorelin, and CJC-1295 Dosage at a Glance

The table above shows the most frequently cited ranges. Reported protocols vary widely, and no large randomized trial has compared all three peptides head to head in healthy adults.

How Each Peptide Is Dosed

Sermorelin

Sermorelin is a 29-amino-acid growth hormone–releasing hormone (GHRH) analog. It is usually injected subcutaneously once nightly, 30 to 60 minutes before sleep, on an empty stomach.

• Common range: 100–300 mcg per injection
• Frequency: once daily
• Short half-life, so a single nightly dose matches the body's natural overnight GH pulse

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that binds the ghrelin receptor and triggers a GH pulse with relatively little effect on cortisol or appetite compared with older secretagogues. Common protocols use 100–300 mcg per dose, one to three times daily.

Every injection is given fasted, because food and insulin can blunt the response. Most users avoid dosing within two hours of a meal.

CJC-1295 (With and Without DAC)

CJC-1295 without DAC, sometimes called modified GRF 1-29, behaves like a short-acting GHRH analog. It is dosed at about 100 mcg per injection and is frequently paired one-to-one with ipamorelin.

CJC-1295 with DAC binds to albumin and stays active for days, so it is dosed at 1–2 mg once or twice weekly instead. The two versions are not interchangeable, and treating a DAC product like a non-DAC product is a common and avoidable mistake.

How Often Do You Inject These Peptides?

People regularly ask how often do you inject cjc-1295 ipamorelin, and the practical answer is one to three times daily for the non-DAC version and once or twice weekly for the DAC version. Sermorelin is almost always once nightly.

• Fasted dosing: inject at least two hours after eating.
• Bedtime anchoring: the largest natural GH pulse occurs in early sleep.
• Site rotation: rotate between abdomen, thigh, and upper arm.
• Consistency: same time, same technique, fresh needle each time.

Stacking Sermorelin, Ipamorelin, and CJC-1295

Because all three peptides push the same growth hormone axis through different doors, stacking them can increase the size and duration of the GH pulse. Stacking also increases the chance of overlapping side effects, which is why most protocols use two peptides rather than three.

If you are comparing cjc-1295 dac with ipamorelin dosage schedules, remember that the DAC portion is dosed weekly while the ipamorelin portion stays daily. Many users report that a sermorelin-only or ipamorelin-only protocol is easier to tolerate than a three-peptide stack.

What These Peptides Are Used For

People researching what is cjc-1295 ipamorelin used for generally describe the same goals: deeper sleep, faster recovery, improved body composition, and higher IGF-1 on blood work. Published cjc 1295/ipamorelin effects in small studies and user surveys point in that direction, but the evidence base remains thin.

Reported timelines tend to look like this:

• 1–2 weeks: deeper sleep, vivid dreams, occasional mild water retention
• 4–8 weeks: changes in recovery and energy, sometimes in skin and hair
• 3–6 months: shifts in body composition, if diet and training support them

These peptides are not fat burners or muscle builders on their own. They do not replace sleep, protein intake, or resistance training.

Side Effects and Safety Considerations

Reported side effects are usually mild and dose-related. They include injection site redness, flushing, headache, dizziness, increased appetite, water retention, tingling or numbness in the hands, and changes in fasting blood sugar.

Talk with a healthcare professional before starting any of these peptides, particularly if you have:

• An active or prior hormone-sensitive cancer
• Pituitary disease, uncontrolled diabetes, or a thyroid disorder
• Pregnancy or breastfeeding status
• A medical condition already managed with prescription medication

Because these peptides raise growth hormone and IGF-1, long-term supraphysiologic exposure is a legitimate concern, and periodic blood work monitoring is standard in clinical settings.

Legality, Sourcing, and How to Get Them

When people ask how to get cjc-1295 ipamorelin, the honest answer is that only sermorelin has a realistic prescription pathway in the United States, through a licensed provider and a compounding pharmacy. Ipamorelin and CJC-1295 are not FDA-approved for human use and are widely sold as research chemicals labeled "not for human consumption."

Products sold online without a prescription carry real risks: unknown purity, incorrect concentration, and no sterility guarantee. Third-party lab reports are worth checking, but they are not a substitute for medical supervision.

Sermorelin is not FDA-approved for general anti-aging or performance use in the United States; its earlier approval covered a diagnostic indication that has since been discontinued. A licensed clinician is the safest starting point for anyone considering these compounds.